• Accueil >
  • Publications >
  • Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice

Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice

1 janv. 2018Thyroid

DOI : 10.1089/thy.2017.0205

Auteurs

Amandine Berdelou, Isabelle Borget, Yann Godbert, Thierry Nguyen, Marie-Eve Garcia, Cécile N. Chougnet, Aurélie Ferru, Camille Buffet, Olivier Chabre, Olivier Huillard, Sophie Leboulleux, Martin Schlumberger, on the behalf of the TUTHYREF Netwo